- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Discovery Laboratories Inc+ Add to Watchlist
DSCO:US1.6100 USD 0.0200 1.26%
As of 17:20:00 ET on 07/30/2014.
Company Profile for Discovery Laboratories Inc (DSCO)
Discovery Laboratories, Inc. is a biopharmaceutical company that develops its proprietary surfactant technology as Surfactant Replacement Therapies (SRT) for respiratory diseases. Through this technology, pulmonary surfactants have the potential to be developed into a series of respiratory therapies for patients in the neonatal care unit, critical care unit and other hospital settings.
Discovery Laboratories Inc
Key Executives for Discovery Laboratories Inc (DSCO)
|John G CooperPresident/CEO||John A TattorySenior VP/CFO|
|Thomas F MillerSenior VP/COO||Russell ClaytonSenior VP:Research & Dev|
|Mary B TempletonSenior VP/Secy/Gen Cnsl||Kathryn A ColeSenior VP:Human Resources|
|Thomas C HoyVP:Manufacturing Ops||William C RobertsVP:Investor Relations|
|Lawrence WeinsteinVP:Medical Device Development||Michael L MageeVP:Quality Operations|